CIK 0001595097 · Non-accelerated filer<br>Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464348039
- Phone
- 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,758,438
- in 2 filings, $16K under 10b5-1 plans
Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-13 | Millian Craig Stuart Chief Operating Officer | Grant or award · Stock Option (right to buy) | +934,645 | 934,645 | ||
| 2023-02-13 | Moran Sean F. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +934,645 | 934,645 | ||
| 2023-02-13 | Cohen Yuval Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,989,546 | 1,949,546 | ||
| 2022-09-26 | Altmeyer Anne Director | Grant or award · Stock Option(right to buy) | +159,200 | 159,200 | ||
| 2022-08-10 | Millian Craig Stuart Chief Operating Officer | Purchase | +5,000 | $0.25 | $1K | 27,000 |
| 2022-08-10 | Cohen Yuval Chief Executive Officer | Purchase | +3,800 | $0.26 | $1K | 98,230 |
| 2022-08-10 | Moran Sean F. Chief Financial Officer | Purchase | +20,000 | $0.26 | $5K | 199,272 |
| 2022-05-18 | Jacques Rachelle Suzanne Director | Grant or award · Stock Option(right to buy) | +79,600 | 79,600 | ||
| 2022-05-18 | HOLMER ALAN F Director | Grant or award · Stock Option(right to buy) | +79,600 | 79,600 | ||
| 2022-05-18 | Jenkins John Kenneth Director | Grant or award · Stock Option(right to buy) | +79,600 | 79,600 | ||
| 2022-05-18 | Salzmann Peter Director | Grant or award · Stock Option(right to buy) | +79,600 | 79,600 | ||
| 2022-05-18 | CATLIN AVERY W Director | Grant or award · Stock Option(right to buy) | +79,600 | 79,600 | ||
| 2022-05-16 | Moran Sean F. Chief Financial Officer | Purchase | +12,000 | $0.30 | $4K | 179,272 |
| 2022-05-16 | Cohen Yuval Chief Executive Officer | Purchase | +10,500 | $0.25 | $3K | 94,430 |
| 2022-03-10 | Millian Craig Stuart Chief Operating Officer | Purchase | +10,000 | $0.37 | $4K | 22,000 |
| 2022-03-10 | Moran Sean F. Chief Financial Officer | Purchase | +15,000 | $0.37 | $6K | 167,272 |
| 2022-03-09 | Cohen Yuval Chief Executive Officer | Purchase | +8,600 | $0.37 | $3K | 83,930 |
| 2022-02-01 | Millian Craig Stuart Chief Operating Officer | Grant or award · Stock Option (right to buy) | +402,900 | 402,900 | ||
| 2022-02-01 | Cohen Yuval Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,489,700 | 1,489,700 | ||
| 2022-02-01 | Brake Rachael Louise Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +570,800 | 570,800 |
Page 10 of 10 · 200 trades